Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model.

Authors :: Oemrawsingh, Rohit M.
Akkerhuis, K. Martijn
Van Vark, Laura C.
Redekop, W. Ken
Rudez, Goran
Remme, Willem J.
Bertrand, Michel E.
Fox, Kim M.
Ferrari, Roberto
Jan Danser, A. H.
de Maat, Moniek
Simoons, Maarten L.
Brugts, Jasper J.
Boersma, Eric
Danser, A H Jan
PERGENE investigators
Source :: Journal of the American Heart Association; Mar2016, Vol. 5 Issue 3, p1-11, 11p
Publication Year :: 2016

Full Text Access

Tools